PharmaShots | Incisive News in 3 Shots

Subscribe Now

genmab

Genmab to Acquire ProfoundBio for Enhancing its Oncology Portfolio

Genmab to Acquire ProfoundBio for Enhancing its Oncology Portfolio

April 3, 2024

Genmab Receives MHLW Approval for Epkinly (epcoritamab) for Adults Patients with Large B-Cell Lymphoma

Genmab Receives MHLW Approval for Epkinly (epcoritamab) for Adults Patients with Large B-Cell Lymphoma

September 25, 2023

Genmab and Seagen Report P-III Trial (innovaTV 301) Results of Tivdak (tisotumab vedotin-tftv) for Recurrent or Metastatic Cervical Cancer

Genmab and Seagen Report P-III Trial (innovaTV 301) Results of Tivdak (tisotumab vedotin-tftv) for Recurrent or Metastatic Cervica...

September 5, 2023

Tahi Ahmadi and Asud Khaliq Share their Views on EPKINLY (epcoritamab) U.S. FDA Approval in DLBCL

Tahi Ahmadi and Asud Khaliq Share their Views on EPKINLY (epcoritamab) U.S. FDA Approval in DLBCL

August 2, 2023

$Genmab and AbbVie Report P-I/II Trial (EPCORE NHL-1) Results of Epcoritamab for the Treatment of Relapsed/Refractory Follicular Lymphoma$

Genmab and AbbVie Report P-I/II Trial (EPCORE NHL-1) Results of Epcoritamab for the Treatment of Relapsed/Refractory Follicular Ly...

June 28, 2023

Genmab Expands its 2015 Agreement with BioNTech to Develop and Commercialize Novel Immunotherapy for Cancer

Genmab Expands its 2015 Agreement with BioNTech to Develop and Commercialize Novel Immunotherapy for Cancer

August 8, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us